http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2687518-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c1ee19e6efdf91c1bf88bde9e9845ef |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 |
| filingDate | 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6b97ea5c29f6d99a0464e0ca0b039d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77072fabd594ab933c682e032552ddb8 |
| publicationDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2687518-T3 |
| titleOfInvention | Pyrazolo [1,5-a] substituted pyridines, their preparation and their use as medicines |
| abstract | A compound of general formula (I): ** Formula ** in which 5 R1 and R2 independently represent hydrogen; a saturated or unsaturated, branched or unbranched aliphatic C1-10 radical; an unsubstituted aryl; an unsubstituted heteroaryl radical; a C3-9 cycloalkyl radical optionally containing at least one heteroatom as a ring member selected from N, O or S and optionally substituted with a C1-6 alkyl group, a phenyl group, a benzyl group, a linear C1-6 alkoxy group or branched, -F, -Cl, -I, -Br, -CF3, -CH2F, -CHF2, -CN, -OH, -SH, -NH2, oxo, - (C> = O) R ', -SR ', -SOR', -SO2R ', -NHR', -NR'R 'so that R' and optionally R '' for each substituent independently represents a linear or branched C1-6 alkyl group; a C1-10 cycloalkylalkyl radical; a C1-10 arylalkyl radical; or a C1-10 heteroarylalkyl radical; or R1 and R2 together with the bridging nitrogen form a C3-9 cycloalkyl optionally containing at least one additional heteroatom as a ring member selected from N, O or S and optionally substituted with a C1-6 alkyl group, a C1- alkoxy group 6 linear or branched, -F, -Cl, -I, -Br, -CF3, -CH2F, -CHF2, -CN, -OH, -SH, - NH2, oxo, - (C> = O) R ', -SR ', -SOR', -SO2R ', -NHR', -NR'R 'so R' and optionally R '' for each substituent independently represents a linear or branched C1-6 alkyl group or with a group selected from: ** Formula ** or R1 and R2 together with the bridge nitrogen form C3-9 cycloalkyl optionally containing at least one additional heteroatom as a ring member selected from N, O or S, which can be condensed to form a system of rings with another C3-9 cycloalkyl optionally containing at least one heteroatom as a ring member selected from N, O or S; or that can be condensed to form a ring system with an aryl radical; or which can be spirocondensed with an aryl or heteroaryl group; R3 represents hydrogen or halogen; n is 0, 1 or 2; m is 1, 2, 3 or 4; and ----- represents an optionally double bond; with the proviso that when R1 and R2 together with the bridge nitrogen form a piperidine, R3 is hydrogen and n is 0, m is not 3; or a pharmaceutically acceptable salt, stereoisomer or solvate thereof. |
| priorityDate | 2012-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 346.